Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Felicetti

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
The American Journal of Medicine|November 26, 2013
Thyroid cancer in cancer survivors: the role of ultrasound and the need for committed specialistsMarco Gallo, Francesco Felicetti, Enrico Brignardello
Diabetes Research and Clinical Practice|February 24, 2018
Cancer survivors: An expanding population with an increased cardiometabolic riskFrancesco Felicetti, Nicoletta Fortunati, Enrico Brignardello
Frontiers of Hormone Research|September 30, 2021
Cardiometabolic Risk, Part 2: Indirect Cardiotoxicity in Cancer Survivors - The Emerging Role of Metabolic SyndromeFrancesco Felicetti, Enrico Brignardello, Janine Nuver
Frontiers of Hormone Research|March 1, 2017
Thyroid Autoimmunity and CancerFrancesco Felicetti, Maria Graziella Catalano, Nicoletta Fortunati
Best Practice & Research. Clinical Endocrinology & Metabolism|December 16, 2016
GH deficiency in adult survivors of childhood cancerFrancesco Felicetti, Nicoletta Fortunati, Emanuela Arvat, et al.
Frontiers of Hormone Research|May 4, 2021
Cancer Treatment-Induced Bone Loss in Hormone-Sensitive Cancer: The Paradigm of Cancer Survivor Bone Health ManagementNicoletta Fortunati, Filippo Gatti, Francesco Felicetti, et al.
Frontiers of Hormone Research|September 28, 2021
PrefaceEnrico Brignardello, Francesco Felicetti, Hanneke M van Santen
Sensors (Basel, Switzerland)|February 13, 2026
Image Quality Standardization in Radiomics: A Systematic Review of Artifacts, Variability, and Feature StabilityFrancesco Felicetti, Francesco Lamonaca, Domenico Luca Carnì, et al.
Expert Review of Anticancer Therapy|October 10, 2017
Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancerFrancesco Felicetti, Alice Nervo, Alessandro Piovesan, et al.
Oncology Letters|July 3, 2015
Pituitary lesions in breast cancer patients: A report of three casesNicoletta Fortunati, Francesco Felicetti, Michela Donadio, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The American Journal of Medicine|November 26, 2013
Thyroid cancer in cancer survivors: the role of ultrasound and the need for committed specialistsMarco Gallo, Francesco Felicetti, Enrico Brignardello
Diabetes Research and Clinical Practice|February 24, 2018
Cancer survivors: An expanding population with an increased cardiometabolic riskFrancesco Felicetti, Nicoletta Fortunati, Enrico Brignardello
Frontiers of Hormone Research|September 30, 2021
Cardiometabolic Risk, Part 2: Indirect Cardiotoxicity in Cancer Survivors - The Emerging Role of Metabolic SyndromeFrancesco Felicetti, Enrico Brignardello, Janine Nuver
Frontiers of Hormone Research|March 1, 2017
Thyroid Autoimmunity and CancerFrancesco Felicetti, Maria Graziella Catalano, Nicoletta Fortunati
Best Practice & Research. Clinical Endocrinology & Metabolism|December 16, 2016
GH deficiency in adult survivors of childhood cancerFrancesco Felicetti, Nicoletta Fortunati, Emanuela Arvat, et al.
Frontiers of Hormone Research|May 4, 2021
Cancer Treatment-Induced Bone Loss in Hormone-Sensitive Cancer: The Paradigm of Cancer Survivor Bone Health ManagementNicoletta Fortunati, Filippo Gatti, Francesco Felicetti, et al.
Frontiers of Hormone Research|September 28, 2021
PrefaceEnrico Brignardello, Francesco Felicetti, Hanneke M van Santen
Sensors (Basel, Switzerland)|February 13, 2026
Image Quality Standardization in Radiomics: A Systematic Review of Artifacts, Variability, and Feature StabilityFrancesco Felicetti, Francesco Lamonaca, Domenico Luca Carnì, et al.
Expert Review of Anticancer Therapy|October 10, 2017
Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancerFrancesco Felicetti, Alice Nervo, Alessandro Piovesan, et al.
Oncology Letters|July 3, 2015
Pituitary lesions in breast cancer patients: A report of three casesNicoletta Fortunati, Francesco Felicetti, Michela Donadio, et al.
Pageof 4